IMMIXBIO Trademark

Trademark Overview

On Tuesday, July 6, 2021, a trademark application was filed for IMMIXBIO with the United States Patent and Trademark Office. The USPTO has given the IMMIXBIO trademark a serial number of 90813912. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, July 25, 2024. This trademark is owned by Immix Biopharma, Inc.. The IMMIXBIO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Tumor suppressing agents
immixbio

General Information

Serial Number90813912
Word MarkIMMIXBIO
Filing DateTuesday, July 6, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, July 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2022

Trademark Statements

Goods and ServicesAnti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Tumor suppressing agents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmix Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90064
Party NameImmix Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90064

Trademark Events

Event DateEvent Description
Saturday, March 26, 2022NON-FINAL ACTION E-MAILED
Friday, July 9, 2021NEW APPLICATION ENTERED
Wednesday, September 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 24, 2022ASSIGNED TO EXAMINER
Saturday, March 26, 2022NON-FINAL ACTION WRITTEN
Saturday, March 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 26, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 9, 2022ASSIGNED TO LIE
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 9, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, November 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 27, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, July 14, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 14, 2023SOU EXTENSION 1 FILED
Friday, July 14, 2023SOU EXTENSION 1 GRANTED
Thursday, January 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 25, 2024SOU EXTENSION 2 FILED
Thursday, January 25, 2024SOU EXTENSION 2 GRANTED
Saturday, January 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, July 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 25, 2024SOU EXTENSION 3 GRANTED
Thursday, July 25, 2024SOU EXTENSION 3 FILED
Tuesday, February 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

immixbio cancer treatment products pharmaceutical preparations suppressing agents tumor prevention anti